SIC 3841 – Surgical and Medical Instruments and Apparatus
Valuation | |
---|---|
Market Cap ($M) | 1,204.87 |
Enterprise Value ($M) | 1,086.84 |
Book Value ($M) | 114.86 |
Book Value / Share | 1.71 |
Price / Book | 10.49 |
NCAV ($M) | 101.85 |
NCAV / Share | 1.51 |
Price / NCAV | 11.83 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.43 |
Return on Assets (ROA) | -1.09 |
Return on Equity (ROE) | -1.48 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 11.88 |
Current Ratio | 11.88 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 119.45 |
Assets | 132.46 |
Liabilities | 17.60 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -54.36 |
Net Income | -53.59 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -36.34 |
Cash from Investing | -0.12 |
Cash from Financing | 110.14 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Duggan Robert W | 70.60 | 0.35 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
37,120 | 213,555 | 17.38 | |
51,625 | 174,860 | 29.52 | |
32,760 | 141,075 | 23.22 | |
47,974 | 221,425 | 21.67 | |
(click for more detail) |
Similar Companies | |
---|---|
NXL – Nexalin Technology, Inc. | PAVM – PAVmed Inc. |
PDEX – Pro-Dex, Inc. | POAI – Predictive Oncology Inc. |
POCI – Precision Optics Corporation, Inc. |